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Abstract
In humans Uncoupling Proteins (UCPs) are a group of five mitochondrial inner membrane transporters with variable tissue
expression, which seem to function as regulators of energy homeostasis and antioxidants. In particular, these proteins
uncouple respiration from ATP production, allowing stored energy to be released as heat. Data from experimental models
have previously suggested that UCPs may play an important role on aging rate and lifespan. We analyzed the genetic
variability of human UCPs in cohorts of subjects ranging between 64 and 105 years of age (for a total of 598 subjects), to
determine whether specific UCP variability affects human longevity. Indeed, we found that the genetic variability of UCP2,
UCP3 and UCP4 do affect the individual’s chances of surviving up to a very old age. This confirms the importance of energy
storage, energy use and modulation of ROS production in the aging process. In addition, given the different localization of
these UCPs (UCP2 is expressed in various tissues including brain, hearth and adipose tissue, while UCP3 is expressed in
muscles and Brown Adipose Tissue and UCP4 is expressed in neuronal cells), our results may suggest that the uncoupling
process plays an important role in modulating aging especially in muscular and nervous tissues, which are indeed very
responsive to metabolic alterations and are very important in estimating health status and survival in the elderly.
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Introduction
Un-Coupling Proteins (UCPs) belong to a family of anion
transporters located in the inner membrane of mitochondria
responsible for uncoupling substrate oxidation from ATP
synthesis. As a consequence stored energy is released as heat. To
date, five UCP homologues, UCP1 to UCP5, have been identified
in mammals. UCP1 (4q28.31), the first member characterized, is
predominantly expressed in brown adipose tissue (BAT), where it
has a well-established role in cold- and diet-induced thermogenesis
[1]. UCP2 and UCP3 share a common region on chromosome
11q13. UCP2 is widely expressed in many organs and tissues [2],
while UCP3 is principally expressed in skeletal muscle, cardiac
muscle, and BAT [3,4]. Finally, UCP4 (6p12.3) and UCP5 (Xp24)
are predominantly expressed in the central nervous system and at
a lower level in other tissues [5,6]. Unlike UCP1, the physiological
role of the other UCPs still remains to be fully elucidated. It has
been hypothesized that these proteins may provide protection
from oxidative damage by preventing excessive production of
mitochondrial Reactive Oxygen Species (ROS) [7,8]. Indeed,
Ucp-knockout mice have increased levels of ROS and show signs
of increased oxidative damage [9–11]. Further evidence indicates
that activation of UCP2 and UCP3 by ROS leads to a mild
uncoupling and to diminished ROS formation [12,13], while their
inhibition by purine nucleotides increases membrane potential and
mitochondrial ROS production [14].
The uncoupling activity of UCPs has also been linked to
regulation of other more specific metabolic functions [15,16] such
as fatty acid oxidation [17], glucose-stimulated insulin secretion
[18], whole body energy balance [19], and apoptosis [20]. Human
aging is characterized by a gradual reduction in the ability to
coordinate cellular energy expenditure and storage (crucial to
maintain energy homeostasis), and by a gradual decrease in the in
the ability to mount a successful stress response [21,22]. These
physiological changes are typically associated with changes in body
composition (i.e increase in fat mass and the decline in fat-free
mass), and with a chronic state of oxidative stress with important
consequences on health status [23–25]. Mitochondrial function is
crucial in these processes, being mitochondria the main cellular
sites controlling energy metabolism and the redox state. Thus, by
promoting fatty acid oxidation, and by reducing ATP and ROS
production, the induction of mitochondrial uncoupling through
UCPs may also be a critical pathway in the modulation of the rate
of aging and lifespan [26–28]. This idea, first proposed by M. D.
Brand [26] and termed ‘‘uncoupling-to-survival’’, is now support-
ed by several experimental evidences (for reviews see: [27,29,30]).
Of interest, targeted expression of exogenous UCP extends
lifespan of adult flies [31,32], while mice with higher metabolism
live longer and have higher uncoupling activity [33]. Transgenic
and knockout mice for Ucp genes show alterations in lifespan
[34,35]. Interestingly, it has also been shown that in vivo
uncoupling mimics metabolic and lifespan effects of calorie
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increased expression of Ucp2 and Ucp3 [37,38].
In humans the correlation between mitochondrial uncoupling
and aging emerges from association studies which support a role
for UCPs in many age-related phenotypic traits involving
alterations in cellular energy homeostasis such as obesity, diabetes
and lipid-related diseases [39–41]. We recently performed a
population-based study in a human cohort of elderly subjects
which demonstrated that UCP3 variability has an impact on hand
grip strength, one of the most important hallmarks of human aging
[42] and more recently we also found that two variants (A-3826G
and C-3740A) in the upstream enhancer region of human UCP1
gene affect the expression of the gene and are correlated with
human longevity [43].
Given the tissue-specific expression of UCP genes, it seems likely
that they may affect the senescence of different tissues with
important effects on the overall aging process and consequently on
lifespan. Thus, the goal of the present study was to assess both the
primary effects of single loci and gene-gene interactions to test the
hypothesis that other UCP genes may contribute to survival at
very old age either independently and/or through complex
interactions.
Methods
Ethical statement
Samples were collected within the framework of several
recruitment campaigns carried out for monitoring the quality of
aging in Calabria from 2002.The recruitment campaigns and
subsequent analyses received the approval of the Ethical
committee of the University of Calabria. All subjects provided
written informed consent for studies on aging carried out by our
research group. White blood cells (WBC) from blood buffy coats
were used as a source of DNA.
The Sample
A total of 598 subjects (293 men and 305 women, age range 64–
105 years; mean ages 82.74 (611.66) and 85.23 (610.84) years,
respectively) participated in this study. All subjects were born in
Calabria (southern Italy) and their ancestry in the region was
ascertained up to the grandparents’ generation. Younger subjects
were contacted through family physicians. Subjects older than 90
years were identified through the population registers and then
were contacted by specialized personnel and invited to join the
study. Each subject underwent a medical visit carried out by a
geriatrician who also conducted an interview including the
administration of a structured questionnaire, validated at Euro-
pean level. The questionnaire collected socio-demographic
information, evaluated physical and cognitive status, and self-
reported health status. Subjects with dementia and/or neurologic
disorders were not included.
The analyses were carried out by dividing the sample into two
specific age classes obtained according to the survival function of
the Italian population from 1890 onward [44]. The two
‘‘thresholds of longevity’’ used to define these age classes were
88 years for men and 91 years for women.
SNPs selection
Polymorphisms within the UCP genes were selected from
literature data, and using information from online databases such
as NCBI dbSNP and HapMap. SNP selection was based on allele
frequency, position, and functional effects. For each gene the
selected SNPs are reported in Table 1.
Genotyping
DNA was prepared from peripheral blood lymphocytes using
standard techniques. Genotyping of the eleven polymorphic sites
was carried out using a TaqMan Real Time PCR (SNP
Genotyping kit, Applied Biosystems). In all assays the fluorescent
FAM dye was used to label the wild-type allele, while the mutant
allele was labeled by fluorescent VIC dye. PCR reactions were
carried out in a total volume of 5 ml containing 20 ng of genomic
DNA, 2.5 ml of TaqMan Universal Master mix (concentration of
26), 0.25 ml of Custom TaqMan SNP Genotyping Assay
(concentration of 206) containing both primers and probes. The
amplification protocol (60uC for 30 seconds, 95uC for 10 minutes
followed by 40 cycles at 95uC for 15 seconds and 60uC for 1
minute) was performed by using a StepOne thermal cycler
(Applied Biosystems). Random regenotyping was conducted to
confirm the results.
Genetic and statistical analyses
For each polymorphism of the UCP genes, allele frequencies
were estimated by counting genes from the observed genotypes.
The Hardy-Weinberg equilibrium (HWE) was tested using the
exact test proposed by [45]. Standard errors for alleles were
computed according to the hypothesis of the multinomial
distribution.
Single-locus analysis
In recent years different robust tests have been proposed to test
genotype-phenotype associations in case-control studies. One of
these is the MAX3 test which assumes the maximum of three
different Cochran-Armitage trend tests (CATTs) evaluated with
respect to three different genetic models of inheritance: dominant,
additive or recessive [46,47]. The main drawback of such tests is
represented by the fact that they could be seriously affected by
confounding factors [48]. In this context, So and Sham recently
proposed a robust association test allowing for quantitative or
binary traits as well as covariates [49]. This test was based on the
score test and has been implemented in the R package RobustSNP.
In the present study the robust association test proposed by So and
Sham was applied to estimate the association between the
variability in the UCP genes and the probability of reaching
advanced ages. In each test we included sex and Body Mass Index
(BMI) as covariates.
Table 1. Description and localization of selected SNPs in the
UCP genes.
Gene
symbol dbSNP ID Physical location
Function
annotation *
UCP2 rs660339 C/T exon 4 Ala55Val
rs659366 G/A 59-proximal region 2866 G/A
UCP3 rs15763 C/T 39UTR
rs1800849 C/T 59-proximal region 255 C/T
UCP4 rs9472817 C/G intron 8
rs10498769 C/G 59UTR
UCP5 rs2235800 A/T intron 7
rs5975178 C/T 59-proximal region
*Provided only for coding SNP (amino acid residues for two alleles) and for SNPs
in the 59 flanking region (the nucleotide positions relative to the transcription
start sites in the promoter regions are indicated).
doi:10.1371/journal.pone.0029650.t001
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Pairwise measures of linkage disequilibrium (LD) between the
analyzed loci were calculated with the Haploview 4.2 [50]. The
amount of LD was quantified by Lewontin’s coefficient (D’).
In order to model the effect of the UCP haplotypes on the
probability to attain longevity we used the haplo.stats package of R.
It implements a haplotype-based association analysis within the
generalized linear model (GLM) framework that allows for
ambiguous haplotypes. The haplo.score function of this package
has been used to obtain the GLM-based score statistics for testing
global and individual haplotype effects on the probability to attain
longevity [51]. Permutation-based p-values were used to evaluate
the significance of the scores obtained (10000 permutations). In
this model the effect of the different haplotypes was assessed
assuming a dominant model after adjusting for sex and BMI.
Interaction analysis
In order to explore the interaction effects between the analyzed
polymorphisms on the probability to be part of the very old age
group, the Model-Based Multifactor Dimensionality Reduction
(MB-MDR) method was applied [52]. In this model only all
possible second order interactions, after adjusting for main effects
sex and BMI, were analyzed.
All statistical analyses were performed using genetics, RobustSNP,
mbmdr and haplo.stats packages of R 2.10.1.
Results
Table 2 reports the socio-demographic characteristics of the
sample analyzed according to age group. The observed genotype
frequencies (Table S1) were in agreement with those expected at
HWE (p.0.01). Table 3 reports the results of the association test
for the three different genetic models (dominant, additive and
recessive) obtained in the analyzed sample using the RobustSNP
algorithm. Table 3 clearly shows that the variability of the UCP
polymorphism was significantly associated with the analyzed
phenotype. In particular, using the minor allele for each SNP as
reference and after adjusting for BMI and sex, the dominant
model for the rs660339 (UCP2) and the rs1800849 (UCP3) resulted
to be significantly associated with the longevity phenotype
(p=0.001 in both cases), while the recessive model was the most
likely for SNPs rs15763 (UCP3), rs9472817 (UCP4) and rs2235800
(UCP5)( p ,0.05). However, after adjusting for multiple testing, all
the previous associations remained statistically significant, except
those for rs2235800 of the UCP5 gene (p=0.058).
From the z-statistics of these models we observed that carriers of
the T allele at rs660339 and at rs1800849 (dominant models)
significantly influenced the probability to be part of the oldest
group (positive scores). For the recessive models, homozygous
subjects for the T allele at rs15763 variation also increased the
probability to be part of the oldest group, while this probability
was significantly decreased (negative score) for homozygous
subjects with the T allele at rs9472817.
By using the MB-MDR approach we did not find any
significant interaction effect among the analyzed polymorphisms
(data not shown).
Subsequently, using the aforementioned GLM-based algorithm,
we evaluated the effect of the UCP haplotypes on the probability to
attain longevity. LD analysis showed that among the four SNPs in
the UCP2-UCP3 gene region rs660339, rs659366 and rs15763
were in moderate LD (see Fig. 1), while rs1800849 was in LD with
rs15763 (D’=0.83), but it was virtually unlinked with the others
(D’,0.30). Finally, we found a weak LD between rs9472817 and
rs10498769 in the UCP4 gene (D’=0.47), and between rs2235800
and rs5975178 in the UCP5 gene (D’=0.44). Based on these LD
patterns, and using a D’ cutoff equal to 0.6, haplotypes were
reconstructed at the UCP2-UCP3 and UCP3 loci.
As shown in Table 4, the analysis of the UCP2-UCP3 haplotypes
revealed that the CAC haplotype, consisting of the minor allele for
rs660339, major allele for rs659366, and minor allele rs15763, was
associated with a decreased probability of attaining longevity (P=
0.003), while the TGT haplotype (opposite combination of alleles)
acted in a reverse fashion by increasing this probability (p=0.046).
However, the strength of these associations was influenced by the
allelic status at rs659366 of the relevant haplotype. Indeed, the
CGC and TAT haplotypes, when compared to the above, differ
only for rs659366 and did not show any effect. For the UCP3
haplotypes involving rs15763 and rs1800849, we found that
carriers of the CC haplotype have a decreased probability of
achieving longevity (P,0.001). Conversely, as previously reported
in the single-locus analysis, the presence of a T allele at either
rs15763 or rs1800849 increased such probability, although this
positive effect was more pronounced when the T allele at
rs1800849 was involved (p=0.044 vs P=0.006).
Discussion
Substantial evidence suggests that the ability of UCPs to reduce
ROS and regulate energy utilization underpins the ability of
UCPs to promote lifespan in various experimental models
[27,28,29,30,35]. In the present study we found that variants in
UCP2, UCP3, and UCP4 significantly affect an individual’s chances
of becoming ultra-nonagenarians. The different localization of the
proteins we found associated with longevity allows us to predict the
areas where the uncoupling process may play an important role in
survival at very old age.
UCP2 and UCP3 genes cluster on chromosome 11q13 in a
region linked to lower resting metabolic rate in humans [53],
which is also syntenic to a region of mouse chromosome 7 linked
to hyperinsulinemia and obesity [54]. Their chromosomal location
and their association with fatty acid transport across mitochondrial
inner membrane and b-oxidation, support the hypothesis that, in
addition to functioning as regulators of oxidative stress, both
UCP2 and UCP3 can modulate cellular energy metabolism
[16,55]. While mounting evidence has documented the impor-
tance of both UCP2 and UCP3 variability in the pathophysiology
of different chronic metabolic diseases, such as diabetes and
obesity [41,56], relatively little is known of their implication in
human aging and longevity. In this study we found that the
Table 2. Socio-demographic characteristics of the analysed
sample according to sex and age group.
Younger group Males Females Total
N( % ) 155 (41.3) 220 (58.7) 375 (100)
Mean age (SD) 72.86 (6.027) 80.64 (9.127) 77.42 (8.858)
BMI (SD) 27.06 (4.122) 26.38 (4.845) 26.66 (4.566)
Older group Males Females Total
N( % ) 138 (61.9) 85 (38.1) 223 (100)
Mean age (SD) 93.85 (3.771) 97.09 (3.235) 95.09 (3.903)
BMI (SD) 24.42 (3.701) 22.50 (3.994) 23.69 (3.918)
Note: age-cut-offs to define the younger and older groups were 88 years for
males and 91 years for females, as reported in Materials and Methods section.
SD: standard deviation.
doi:10.1371/journal.pone.0029650.t002
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rs15763 of UCP3 were significantly associated with survival at very
old age after Bonferroni correction.
Ala55val SNP in exon 4 causes a conservative amino acid
change that does not seem to cause a functional change in the
protein. However, it has been reported that the Val/Val genotype
causes a lower degree of uncoupling, an enhanced metabolic
efficiency, and a lower fat oxidation than the Ala/Ala and Ala/Val
genotypes [57]. In addition this genotype has been associated to
higher exercise energy efficiency [58], higher risk in obesity, higher
incidence of diabetes [59,60], and a higher acute insulin response
to glucose [61]. Moreover, individuals with the Val/Val genotype
had greater weight loss and a higher BMI [62]. Nevertheless, other
studies have produced conflicting results [63–66]. Here we show
that this polymorphism also contributes to extend lifespan. Given
the wide distribution of UCP2, it is likely that systemic effects on
global energy metabolism and redox state underlie the association
with longevity. However, UCP2 also exhibits tissue-specific
regulation suggesting tissue specific physiological effects. In this
regard, evidence has been provided that in the brain, liver and
other tissues UCP2 functions as regulator of oxidative stress
[67–69], in the heart as a regulator of energy availability [70], in
white adipose tissue and skeletal muscle as a regulator of fatty acid
metabolism [71,72], and as a regulator of insulin dynamics in
pancreatic b and a-cells [73,74]. In this scenario, variants of UCP2
may have positive and negative effects depending on the tissue and
on the fine balance between energy production/consumption and
mitochondrial ROS generation.
It is widely accepted that damage by free radicals to the
molecules with which they come into contact are the underlying
cause of aging, therefore the ability of UCP2 to attenuate steady-
state levels of ROS strongly suggests an essential role in lifespan
extension. Recently, Andrews proposed that UCP2 promotes
longevity by shifting a cell towards fatty acid fuel utilization thus
pointing to a major role of UCP2 in modulating metabolism [75].
This hypothesis is somewhat supported by Barbieri and colleagues
Table 3. Results of the Robust SNP association test for the most likely genetic model (additive, recessive and dominant) obtained
in the analyzed sample.
Gene SNP MAF Z(ADD) Z(REC) Z(DOM) P(ADD) P(REC) P(DOM) P-value*
UCP2 rs659366 A (0.295) 0.936 0.338 0.978 0.349 0.735 0.328 0.555
rs660339 T (0.341) 3.049 1.477 3.190 0.002 0.140 0.001 0.003
UCP3 rs15763 T (0.247) 2.163 2.468 1.454 0.031 0.014 0.146 0.029
rs1800849 T (0.099) 2.788 21.197 3.186 0.005 0.231 0.001 0.003
UCP4 rs9472817 G (0.498) 21.984 23.607 0.316 0.047 ,0.001 0.752 0.001
rs10498769 G (0.190) 20.085 20.660 0.130 0.933 0.509 0.897 0.761
UCP5 rs2235800 A(0.387) 1.554 2.120 0.849 0.120 0.034 0.396 0.058
rs5975178 C (0.474) 0.203 0.210 0.170 0.839 0.833 0.865 0.959
Z(ADD), Z(REC) and Z(DOM) are the z-statistics under the additive, recessive and dominant models respectively. P(ADD), P(REC) and P(DOM) are the p-values under the
three genetic models.
*p-value was adjusted for multiple testing of different genetic models obtained by the proposed analytic approach.
MAF: Minor Allele Frequency.
doi:10.1371/journal.pone.0029650.t003
Figure 1. Schematic representation of linkage disequilibrium
(D’ coefficient) among the four SNPs of the UCP2-UCP3 gene
cluster.
doi:10.1371/journal.pone.0029650.g001
Table 4. Estimation of haplotype frequencies in the UCPs
SNPs and association with longevity in the analyzed sample.
Gene SNPs Freq
a Score P-value
b
UCP2-UCP3 rs660339 rs659366 rs15763
CA C 0 . 0 2 9 22.876 0.003
CG C 0 . 5 9 6 21.747 0.086
C G T 0.028 0.317 0.754
C A T 0.004 0.877 0.400
T A C 0.077 0.953 0.347
T G C 0.050 0.971 0.339
T A T 0.184 1.390 0.165
T G T 0.030 1.985 0.046
UCP3 rs15763 rs1800849
C C 0.659 23.720 ,0.001
T C 0.243 2.029 0.044
C T 0.095 2.766 0.006
aEstimated haplotype frequency.
bMonte-Carlo p-value from 10
4 replications.
Note: p-values of global score statistics based on 10
4 replications were 0.047 for
UCP2-UCP3 haplotypes, 0.0028 for UCP3 haplotypes.
doi:10.1371/journal.pone.0029650.t004
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of elderly subjects from an Italian population. Although the
authors did not find an association with longevity, they found that
individuals with the Val/Val genotype had significantly higher
energy expenditure parameters. Interestingly, the A-IGF1R/Asp-
IRS2/Val-UCP2 allele combination was associated with a better
metabolic profile, higher energy expenditure parameters, and
lower mortality rates in longevity, thus indicating a contribution of
Ala55val polymorphism to the regulation of energy balance and
survival [76]. The latter and our finding suggest that the 55Val
allele might promote longevity by conferring protection towards
age-related decline of metabolic rate. It is indeed well-known that
human aging is accompanied by a decrease in resting metabolic
rate, the largest component of total energy expenditure, which
significantly affects disability and morbidity among the elderly
[24,77]. On the other hand, long-lived subjects show a preserved
metabolic profile being less prone to the metabolic deregulation
normally occurring with aging [78]. Accordingly, Rizzo and
colleagues [79] reported that compared to aged subjects, healthy
long-lived subjects display energy expenditure parameters that are
closer to the values of healthy middle-aged adults. In a recent
study we demonstrated a correlation between the activity of UCP1
and human survival, and hypothesized a slower decline of energy
expenditure with age at the basis of the correlation [43].
Skeletal muscle, where UCP3 is mainly expressed, contributes
considerably to the basal metabolic rate [80]. We found that
carriers of the TT genotype (rs15763), and carriers of the -55 T
allele (rs180084) were significantly over-represented among long-
lived subjects. The rs15763 is located in the 39UTR of the gene
and has no clear functional role so far; on the contrary, the -55 T
allele has been associated with a significantly increased gene
expression and has been shown to positively modulate the resting
metabolic rate of skeletal muscle [81,82]. In addition, the over-
expression of UCP3 in muscle cells has been shown to be
associated with decreased production of ROS as well as with
facilitating fatty acid oxidation [17,83]. The physiological status of
the muscle mass reflects a complex equilibrium between nutrition,
metabolism and the response to stress. Aging muscle is
characterized by a progressive loss of mass and a gradual increase
of weakness leading to sarcopenia, a condition associated with
physical disability, and with an increased risk of developing
disorders such as atherosclerosis, type II diabetes and hypertension
[84]. Sarcopenia is closely linked to a decrease in resting metabolic
rate as well as to mitochondrial dysfunction and oxidative stress
[85]. Therefore, in the context of the proposed functions of UCP3,
the physiological consequence of an increased UCP3 activity in
skeletal muscle might be to slow down the age related decline of
muscle performance as a result of decreased ROS production, an
increased protection of mitochondria from lipid peroxidation, and
better metabolic efficiency [28,83]. Accordingly, it has been found
that mild uncoupling has an impact on cellular aging in human
muscles in vivo [86]. This is in keeping with our previous work,
where we have shown that the hand grip strength, the most
effective death predictor in the elderly, was higher in the carriers of
rs1800849-T allele than in the remaining the population [42].
Haplotype analysis confirmed the single SNP analyses, and
highlighted the importance of the entire UCP2-UCP3 locus in
human aging and longevity. In fact, one findingof interest emerging
from this analysis is that the UCP2-rs659366 (-866 G/A), which was
uninformative to single-locus analysis, seemed instead to be effective
in modulating the aging process. In particular the rs659366G allele
appeared to exert a modest beneficial effect on human survival.
Indeed, the presence of the rs659366G allele reduced the negative
effect of the rs659366C-rs15763C haplotype, while it increased the
positive effect of the rs659366T-rs15763T haplotype. The rs659366
(-866G/A) variant changes promoter activity, affects metabolic rate
and oxidative stress, and has been associated with metabolic traits in
several, although not all, studies [87].
UCP4 and UCP5, together with UCP2, are known as neuronal
UCPs due to their widespread distribution in the brain [6]. Neurons
have a very high metabolic rateand consequently a high production
of ROS. Andrews and co-workers observed that neuronal
uncoupling activity leads to decreased ROS levels, a decreased
Ca2+ voltage-dependent influx and increased local temperature in
neuronal microenvironment [88]. We found that only the UCP4
rs9472817-GG genotype negatively impacts on the probability to
attain longevity. It has been shown that UCP4 activity can induce
an adaptive shift in energy metabolism, from mitochondrial
respiration to glycolysis, that helps sustain neurons under conditions
of metabolic and oxidative stress [89,90]. Therefore, by decreasing
free radical production and stabilizing cellular calcium homeostasis,
UCPs expressed in neurons may positively influence neuronal
function (synaptic transmission and plasticity) and retardthe cellular
deterioration associated with aged-related neurological disorders.
Accordingly, the expression of UCP4 has been found significantly
reduced in brains of subjects affected by Alzheimer disease [91].
Moreover, it was found that CC genotype for rs10807344 of UCP4
gene, not found to be associated in the present study with the
longevity phenotype, exerts a protective effect on the occurrence of
multiple sclerosis and of leukoaraiosis, a vascular demyelinization of
the white matter of the brain [92,93]. Thus, it is likely that variants
affecting the UCP4 function might have consequences on the aging
of the nervous system, and then might have a potential impact on
health and longevity. Due to the fact that rs9472817 is located in
intron 8, the exact molecular mechanism responsible for the effect
on survival remains to be elucidated. Although it has been reported
that intronic SNPs may have an effect on gene expression [94], it is
more plausible for rs9472817 to be in LD with some other
functional genetic alterations affecting the function of UCP4 and
this has consequences on the aging nervous system, leading to the
observed detrimental effect of the GG genotype. Further studies are
needed to clarify this point.
In conclusion, we found that the genetic variability of UCP genes
affects human longevity. This finding is in agreement with previous
data showing that energy storage and expenditure have a key role in
survival at old age and support the Uncoupling-to-survive
hypothesis. Although this hypothesis was initially based on the
possible effects of UCPs on the oxidative stress, the most recent data
have emphasized the impact of UCP variations on the metabolic
efficiency. It is then likely that the impactof UCPs’ gene variation on
longevity is due to the complexity of these functions rather than the
sole effectofoxidativestress. Ontheotherhand,dueto the presence
of different UCP genes, each active in specific tissues, further
analyses will be necessary to understand the specific role of the
uncoupling process in different tissues and, consequently, in
correlation with differing metabolism and, possibly, nutrients.
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